Auxly Cannabis Sees Imperial Brands Grant Two Year Extension To Debentures

Auxly Cannabis (TSXV: XLY) has managed to obtain an extension to certain outstanding debts held by Imperial Brands. Announced this morning, certain amendments have been made to the debt that appear to largely be in favour of Auxly.

The extension to outstanding debts dates back to a September 2019 investment into the company by that of Imperial Brands to the tune of $123 million, which was conducted via unsecured convertible debentures at 4% interest. Originally set to expire in September 2022, the debt has now been extended for a period of two years to September 2024.

In addition to the extension of the maturity date, the company will also see interest able to be payable in common shares which appears to be at the decision of Imperial. The interest rate will also remain unchanged, but is now payable on maturity of the debenture. The company has also seen certain approval rights granted to Imperial, however specifics were not provided.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The changes remain subject to shareholder approval.

Auxly Cannabis last traded at $0.37 on the TSX Venture.


Information for this briefing was found via Sedar and Auxly Cannabis Group Inc. The author has no affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Auxly Potentially Hours Away From Securing Curative Cannabis Assets

Auxly Cannabis (TSXV: XLY) is potentially only moments away from finally securing the assets of...

Tuesday, November 26, 2019, 02:31:10 PM

Auxly Cannabis Sees Revenues Decline From Fourth Quarter To $22.6 Million

Growth appears to be starting to slow for Auxly Cannabis (TSX: XLY). The firm this...

Monday, May 16, 2022, 07:56:35 AM

Auxly Cannabis Clarifies FSD Pharma Joint Venture Termination

Auxly Cannabis (TSXV: XLY, OTCMKTS: CBWTF) clarified yesterday the termination of its joint venture with...

Friday, February 8, 2019, 02:00:35 PM

Auxly Cannabis Records 2019 Revenues of $8.3 Million, Net Loss of $108.6 Million

Auxly Cannabis (TSXV: XLY) reported its fourth quarter and full fiscal year earnings late last...

Thursday, April 30, 2020, 09:10:17 AM

FSD Pharma Ends Class Action Lawsuit With $5.5 Million Settlement

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) this morning announced that it has settled a class...

Thursday, October 29, 2020, 12:10:07 PM